Bhaskaran K., Mussini C., Antinori A., Walker A.S., Dorrucci M., Sabin C., Phillips A., Porter K. Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy // Ann Neurol.- 2008.- Vol. 63.- P. 213-221.

Power C., Boisse L., Rourke S., Gill M.J. NeuroAIDS: an evolving epidemic // Can J Neurol Sci.- 2009.- Vol. 36.- P 285-295.

McArthur J.C., Steiner J., Sacktor N., Nath A. Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap // Ann Neurol.- 2010.- Vol. 67. P. 699-714.

Бобкова М.Р. Иммунитет и ВИЧ-инфекция // М.: Олимпия Пресс, 2006.- 240 с.

Simioni S., Cavassini M., Annoni J.-M., Rimbault A. A., Bourquin I., Schiffer V., Calmy A., Chave J.-P., Giacobini E., Hirschel B., Du Pasquier R. A. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia // AIDS.- 2010.- Vol. 24.- P 1243-1250.

Ellis R. J., Badiee J., Vaida F., Letendre S., Heaton R.K., Clifford D., Collier A.C., Gelman B., McArthur J., Morgello S., McCutchan J.A., Grant I. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy // AIDS.- 2011.- Sep.- Vol. 25 (14).- P. 1747-1751.

Marcotte T.D., Ghate M., Deutsch R., Letendre S., Meyerl R.A., Godbole S., Risbud A., Thakar M., Grant I., Mehendale S. Earlier initiation of antiretroviral therapy results in better neurocognitive functioning. [Electronic resource] // Paper presented at the 19th Conference on Retroviruses and Opportunistic Infections.- Washington, USA, 2012.- URL:http://www.retroconference.org/2012b/PDFs/485.pdf (дата обращения: 23.03.2013).http://www.retroconference.org/2012b/PDFs/485.pdf

Беляков Н.А., Медведев С.В., Трофимова Т.Н., Рассохин В.В., Дементьева Н.Е., Шеломов С.А. Механизмы поражения головного мозга при ВИЧ-инфекции // Вестник Российской академии медицинских наук.- 2012. - № 9. - С. 4-12.

Everall I., Vaida F., Khanlou N., et al. Clinico-neuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy // J. Neurovirol.- 2009.- Vol. 15.- P 360-370

Antinori A., Arendt G., Becker J.T., Brew B.J., Byrd D.A., Byrd D.A., Cherner M., Clifford D.B., Cinque P., Epstein L.G., Goodkin K., Gisslen M., Grant I., Heaton R.K., Joseph J., Marder K., Marra C.M., McArthur J.C., Nunn M., Price R.W., Pulliam L., Robertson K.R., Sacktor N., Valcour V., Wojna V.E. Updated research nosology for HIV-associated neurocognitive disorders // Neurology.- 2007.- Vol. 69.- P. 1789-1799.

Letendre S.L., Ellis R.J., Ances B.M., Mc-Cutchan J.A. Neurologic complications of HIV disease and their treatment // Top HIV Med.- 2010.- Vol. 18.- P 45-55.

Soulie C., Fouratia S., Lambert-Niclota S., Malet I., Wirden M., Tubiana R., Valantin M.-A., Katlama C., Calvez V., Marcelin A.-G. HIV genetic diversity between plasma and cerebrospinal fluid in patients with HIV encephalitis // AIDS. - 2010.- Vol. 24 (15). - Р. 2412-2414.

Valcour V., Paul R., Chiao S., Wendelken L.A., Miller B. Screening for cognitive impairmentin human immunodeficiency virus // Clin. Infect Dis. - 2011.- Vol. 53.- P 836-842.

Liu Y., Tang X.P., McArthur J.C., Scott J., Gartner S. Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain // J. Neurovirol. - 2000.- May.- Vol. 6 (1).- P 70-81.

Buckner C. M., Calderon T. M., Willams D. W., Belbin T.J., Berman J.W. Characterization of monocyte maturation/differentiation that facilitates their transmigration across the blood-brain barrier and infection by HIV: implications for NeuroAIDS // Cell. Immunol.- 2011.- Vol. 267 (2).- P 109-123.

Williams D. W., Eugenin E. A., Calderon T. M., Berman J. W. Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis // J. Leukoc. Biol.- 2012.- Mar.- Vol. 91 (3).- P 401-415.

Verma A. S., Singh U. P., Dwivedi P. D., Singh A. Contribution of CNS cells in NeuroAIDS // J. Pharm. Bioallied Sci.- 2010.- Oct.- Vol. 2 (4).- P. 300-306.

Cali C., Bezzi P. CXCR4-mediated glutamate exocytosis from astrocytes // J. Neuroimmunol.- 2010.- Jul.- Vol. 224 (1-2).- P 13-21.

Gabuzda D., Wang J. Chemokine receptors and mechanisms of cell death in HIV neuropathogenesis // J. Neurovirol.- 2000.- May.- Vol. 6 (1).- P 24-32.

Merino J. J., Montes M. L., Blanco A., Bustos M.J., Oreja-Guevara C., Bayon C., Cuadrado A., Lubrini G., Cambron I., Munoz A., Cebolla S., Gutierrez-Fernandez M., Bernardino J.I., Arribas J.R., Fiala M. HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system] // Rev Neurol.- 2011.- Jan.- Vol. 52 (2).- P 101-111.

Nakagawa S., Castro V., Toborek M. Infection of human pericytes by HIV-1 disrupts the integrity of the blood-brain barrier // J. Cell. Mol. Med.- 2012.- Dec.- Vol. 16 (12).- P. 2950-2957.

Churchill M. J., Wesselingh S.L., Cowley D., Pardo C.A., McArthur J.C., Brew B.J., Gorry P.R. Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia // Ann. Neurol.- 2009.- Aug.- Vol. 66 (2).- P 253-258.

Eugenin E.A., Clements J.E., Zink M.C., Berman J.W. Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism // J. Neurosci.- 2011.- Jun.- Vol. 31 (26). - P 9456-9465.

Liu Y., Liu H., Kim B. O., Gattone V.H., Li J., Nath A., Blum J., He J.J. CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor // J. Virol.- 2004.- Apr.- Vol. 78 (8).- P 4120-4133.

Brack-Werner R. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis // AIDS.- 1999.- Jan.- Vol. 13 (1).- P 1-22.

Bissel S.J., Wiley C.A. Human immunodeficiency virus infection of the brain: pitfalls in evaluating infected/affected cell populations // Brain Pathol. - 2004.- Jan.- Vol. 14 (1).- P 97-108.

Strazza M., Pirrone V., Wigdahl B., Nonnemacher M.R. Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier // Brain Res. - 2011.- Jul.- Vol. 1399.- P. 96-115.

Lokensgard J.R., Cheeran M.C., Hu S., Gekker G., Peterson P.K. Glial cell responses to herpesvirus infections: role in defense and immunopathogenesis // J. Infect. Dis.- 2002.- Dec.- Vol. 186 (2).- P S171-179.

Roberts T. K., Eugenin E. A., Lopez L., Romero I.A., Weksler B.B., Couraud P.O., Berman J.W. CCL2 disrupts the adherens junction: implications for neuroinflammation // Lab. Invest.- 2012.- Aug.- Vol. 92, (8).- P 1213-1233.

Dunfee R.L., Thomas E.R., Gorry P.R., Wang J., Taylor J., Kunstman K., Wolinsky S.M., Gabuzda D. The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia // Virology. - 2007.- Vol. 367 (1).- Р 222-234.

Shapshak P., Kangueance P., Fujimura R.K., et al. Неврологические проявления ВИЧ-инфекции // AIDS, русское издание.- 2011.- Т. 4, № 1.- С. 3-21.

Kaul M., Garden G.A., Lipton S.A. Pathways to neuronal injury and apoptosis in HIV-associated dementia // Nature.- 2001.- Vol. 410.- P 988-994.

Power C., Gill M.J., Johnson R.T. Progress in clinical neurosciences: The neuropathogenesis of HIV infection: host-virus interaction and the impact of therapy // Can. J. Neurol. Sci.- 2002.- Vol. 29.- P. 19-32.

Navia B.A., Cho E.S., Petito C.K., Price R.W. The AIDS dementia complex: II. Neuropathology // Ann Neurol. 1986.- Vol. 19.- P. 525-535

Bell J.E. An update on the neuropathology of HIV in the HAART era // Histopathology.- 2004.- Vol. 45.- P 549-559.

Bachis A., Aden S. A., Nosheny R.L., Andrews P.M., Mocchetti I. Axonal transport of human immunodeficiency virus type 1 envelope protein glycoprotein 120 is found in association with neuronal apoptosis // J. Neurosci.- 2006. - Jun.- Vol. 26, no. 25.- P 6771-6780.

Conant K., Hillaire C. St., Anderson C., Galey D., Wang J., Nath A. Human immunodeficiency virus type 1 Tat and methamphetamine affect the release and activation of matrix-degrading proteinases // J. Neurovirol.- 2004. - Feb. - Vol. 10 (1). - P 21-28.

Toschi E., Barillari G., Sgadari C., Bacigalupo I., Cereseto A., Carlei D., Palladino C., Zietz C., Leone P., Sturzl M., Butto S., Cafaro A., Monini P., Ensoli B. Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor // Mol. Biol. Cell.- 2001.- Oct.- Vol. 12, no. 10.- P 2934-2946.

Lopez-Herrera A., Liu Y., Rugeles M.T., He J.J. HIV-1 interaction with human mannose receptor (hMR) induces production of matrix metalloproteinase 2 (MMP-2) through hMR-mediated intracellular signaling in astrocytes // Biochim. Biophys. Acta.- 2005.- Jun.- Vol. 1741 (1-2).- P. 55-64.

Хоффман К., Рокштро Ю.К. Лечение ВИЧ-инфекции 2011.- М.: Р.Валент,- 2012.- 736 с.

Letendre S., Marquie-Beck J., Capparelli E., Best B., Clifford D., Collier A.C., Gelman B.B., McArthur J.C., McCutchan J.A., Morgello S., Simpson D., Grant I., Ellis R.J. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system // Arch Neurol.- 2008.- Vol. 65.- P 65-70.

Robertson K.R., Su Z., Margolis D.M., Krambrink A., Havlir D.V., Evans S., Skiest D.J. Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort // Neurology.- 2010.- Vol. 74.- P 1260-1266.

Ciccarelli N., Fabbiani M., Di Giambenedetto S., Fanti I., Baldonero E., Bracciale L., Tamburrini E., Cauda R., De Luca A., Silveri M.C. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients // Neurology.- 2011.- Vol. 76.- P. 1403-1409.

Cantres Y., Plaud-Valentin M., Melndez V. Increased cystatin B and cathepsin B in monocytes and post-mortem Brain tissue in HAND: Key Link for Neuropathogenesis // 19th Conference on Retroviruses and Opportunistic Infections (CROI). March 5-8, 2012; Seattle, Washington. Abstract 459.

Samikkannu T., Agudelo M., Gandhi N., Reddy P.V., Saiyed Z.M., Nwankwo D., Nair M.P. Human immunodeficiency virus type 1 clade B and C gp120 differentially induce neurotoxin arachidonic acid in human astrocytes: implications for neuroAIDS // J. Neurovirol.- 2011.- Vol. 17 (3).- Р. 230-238.

Li W., Huang R., Reid J., Steiner J., Malpica-Llanos T., Darden T.A., Shankar S.K., Mahadevan A., Satishchandra P., Nath A. NMDA receptor activation by HIV-Tat protein is clade dependent // J. Neurosci.- 2008.- Vol. 28.- Р. 12190-12198.

Rumbaugh J.A., Nath A. Developments in HIV neuropathogenesis // Curr. Pharm. Des.- 2006.- Vol. 12 (9).- P. 1023-1044.

Dallasta L.M., Pisarov L.A., Esplen J.E., Achim C.L. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis // Am. J. Pathol.- 1999.- Dec.- Vol. 155(6).- P. 1915-1927.

Letendre S.L. Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder // Top Antivir Med.- 2011.- Vol. 19 (4).- P 137-142

Heindel W.C., Jernigan T.L., Archibald S.L., Achim C.L., Masliah E., Wiley C.A. The relationship of quantitative brain magnetic resonance imaging measures to neuropathologic indexes of human immunodeficiency virus infection // Arch Neurol. - 1994.- Vol. Nov. 51(11).- P 1129-35.

Cohen R.A., Harezlak J., Schifitto G., Hana G., Clark U., Gongvatana A., Paul R., Taylor M., Thompson P., Alger J., Brown M., Zhong J., Campbell T., Singer E., Daar E., McMahon D., Tso Y., Yiannoutsos C.T., Navia B. Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in highly active antiretroviral therapy era // J. Neurovirol.- 2010.- Vol. 16 (1).- P. 25-32.

Gray F., Scaravilli F., Everall I., Chretien F., An S., Boche D., Adle-Biassette H., Wingertsmann L., Durigon M., Hurtrel B., Chiodi F., Bell J., Lantos P. Neuro-pathology of early HIV-1 infection // Brain Pathol.- 1996.- Vol. 6.- P 1-15.

Price R.W., Brew B., Sidtis J., Rosenblum M., Scheck A.C., Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex // Science.- 1998.- Vol. 239.- P. 586-592.

Gosztonyi G., Artigas J., Lamperth L., Webster H.D. Human immunodeficiency virus (HIV) distribution in HIV encephalitis: study of 19 cases with combined use of in situ hybridization and immunocytochemistry // J. Neuropathol. Exp. Neurol.- 1994.- Vol. 53. P 521-534.

Kumar A.M., Borodowsky I., Fernandez B., Gonzalez L., Kumar M. Human immunodeficiency virus type 1 RNA Levels in different regions of human brain: quantification using real-time reverse transcriptase-polymerase chain reaction // J. Neurovirol.- 2007. - Vol. 13.- P. 210-224.

Kure K., Weidenheim K.M., Lyman W.D., Dickson D.W. Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDSencephalitis. Pattern of involvement resembling a multisystem degeneration // Acta Neuropathol.- 1990.- Vol. 80.- P. 393-400.

Granziera C., Daducci A., Simioni S., Cavassini M., Roche A., Meskaldji D., Kober T., Metral M., Calmy A., Helms G., Hirschel B., Lazeyras F., Meuli R., Du Pasquier R.A. Micro-Structural Brain Alterations in Aviremic HIV+ Patients with Minor Neurocognitive Disorders: A Multi-Contrast Study at High Field // 2013.- PLoS One.- Vol. Sep 10.- P 8(9).

Pfefferbaum A., Rosenbloom M.J., Rohlfing T., Kemper C.A., Deresinski S., Sullivan E.V. Frontostriatal fiber bundle compromise in HIV infection without dementia // AIDS.- 2009.- Vol. 23.- P. 1977-1985.

Ragin A.B., Wu Y., Storey P., Cohen B.A., Edelman R.R., Epstein L.G. Diffusion tensor imaging of subcortical brain injury in patients infected with human immunodeficiency virus // J. Neurovirol.- 2005. - Vol. 11.- P. 292-298

Ragin A.B., Storey P., Cohen B.A., Edelman R.R., Epstein L.G. Disease burden in HIV-associated cognitive impairment: a study of whole-brain imagingmeasures // Neurology.- 2004.- Vol. 63.- P. 2293-2297.

Ragin A.B., Storey P., Cohen B.A., Epstein L.G., Edelman R.R. Whole brain diffusion tensor imaging in HIV-associated cognitive impairment // AJNR Am J. Neuroradiol.- 2004.- Vol. 25.- P 195-200.

Wu Y., Storey P., Cohen B.A., Epstein L.G., Edelman R.R., Ragin A.B. Diffusion alterations in corpus callosum of patients with HIV // AJNR Am J Neuroradiol.- 2006.- Vol. 27.- P 656-660.

Muller-Oehring E.M., Schulte T., Rosenbloom M.J., Pfefferbaum A., Sullivan E.V. Callosal degradation in HIV-1 infection predicts hierarchical perception: a DTI study // Neuropsychologia.- 2010.- Vol. 48.- P 1133-1143.

Castelo J.M.B., Courtney M.G., Melrose R.J., Stern C.E. Putamen hypertrophy in nondemented patients with human immunodeficiency virus infection and cognitive impairments // Archives of Neurology. - 2007.- Vol. 64 (9). - P. 1275-1280.

Stubbe-Drger B., Deppe M., Mohammadi S., Keller S.S., Kugel H., Gregor N., Evers S., Young P., Ringelstein E.-B., Arendt G., Knecht S., Husstedt I.W. Early microstructural white changes in patients with HIV: A diffusion tensor imaging study // BMC Neurol. - 2012.- Vol. 12.- P 23.

Cole M.A., Castellon S.A., Perkins A.C., Ureno O.S., Robinet M.B., Reinhard M.J., Barclay T.R., Hinkin C.H. Relationship between psychiatric status and frontal-subcortical systems in HIV-infected individuals // J. IntNeuropsychol Soc.- 2007.- Vol. 13.- P. 549-554.

Melrose R.J., Tinaz S., Castelo J.M.B., Courtney M.G., Stern C.E. Compromised fronto-striatal functioning in HIV: An fMRI investigation of semantic event sequencing // Behavioural Brain Research.- 2008.- Vol. 188 (2).- P 337-347

Clark U.S., Cohen R.A., Westbrook M.L., Devlin K.N., Tashima K.T. Facial emotion recognition impairments in individuals with HIV // Journal of the International Neuropsychological Society.- 2010.- Vol. 16 (6).- P 1127-1137.

Jernigan T.L., Archibald S.L., Fennema-Notestine C., Taylor M.J., Theilmann R.J., Julaton M.D., Notestine R.J., Wolfson T., Letendre S.L., Ellis R.J., Heaton R.K., Gamst A.C., Franklin D.R. Jr., Clifford D.B., Collier A.C., Gelman B.B., Marra C., McArthur J.C., McCutchan J.A., Morgello S., Simpson D.M., Grant I. Clinical factors related to brain structure in HIV: the CHARTER study // Journal of Neurovirology. - 2011.- Vol. 17 (3).- P. 248-257.

Patel S.H., Kolson D.L., Glosser G., Matozzo I., Ge Y., Babb J.S., Mannon L.J., Grossman R.I. Correlation between percentage of brain parenchymal volume and neurocognitive performance in HIV-infected patients // AJNR Am J. Neuroradiol.- 2002.- Vol. Apr. 23 (4).- P 543.

Patel S.H., Inglese M., Glosser G., Kolson D.L., Grossman R.I., Gonen O. Whole-brain N-acetylaspartate level and cognitive performance in HIV infection // AJNR Am J. Neuroradiol.- 2003.- Vol. Sep 24 (8).- P 1587-91.

Paul R.H., Ernst T., Brickman A.M., Yiannoutsos C.T., Tate D.F., Cohen R.A., Navia B.A. Relative sensitivity of magnetic resonance spectroscopy and quantitative magnetic resonance imaging to cognitive function among nondemented individuals infected with HIV ACTG 301 team, ACTG 700 team, HIV MRS Consortium // J. Int. Neuropsychol. Soc.,- 2008.- Vol. Sep. 14 (5).- P 725-33.

Paul R.H., Yiannoutsos C.T., Miller E.N., Chang L., Marra C.M., Schifitto G., Ernst T., Singer E., Richards T., Jarvik G.J., Price R., Meyerhoff D.J., Kolson D., Ellis R.J., Gonzalez G., Lenkinski R.E., Cohen R.A., Navia B.A. Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity // J. Neuropsychiatry Clin Neurosci.- 2007.- Vol. 19.- P 283-292.

Трофимова А.В., Трофимова Т.Н., Катаева Г.В., Рассохин В.В., Медведев С.В., Коротков А.Д., Малахова Е.С. Метаболические изменения в веществе головного мозга при ВИЧ-инфекции по данным 3Т МР спектроскопии // ВИЧ-инфекция и иммуносупрессии.- 2012.- Т. 4, № 4.- С. 129-130.

Dulioust A., Lerolle N., Dolphin P., Boufassa F., Duracinsky M., Delfraissy J-F., Goujard C., Gasnault J. High frequency of neurocognitive disorders in older HIV-infected patients despite a sustained virological and immunological response on cART: The sigma study. [Electronic resource] // Paper presented at the 16th Conference on Retroviruses and Opportunistic Infections.- Montreal, Canada, 2009.- URL: http://www.natap.org/2009/CROI/croi_116.htm (дата обращения: 23.03.2013).http://www.natap.org/2009/CROI/croi_116.htm

Ances B., Ortega M., Vaida F., Heaps J., Paul R. Independent Effects of HIV, Aging, and HAART on Brain Volumetric Measures // 19th Conference on Retroviruses and Opportunistic Infections (CROI). March 5-8, 2012; Seattle, Washington. Abstract 514.- URL: http://www.natap.org/2012/CROI/CROI.htm (дата обращения: 23.03.2013).http://www.natap.org/2012/CROI/CROI.htm

Mocchetti I., Campbell L.A., Harry G.J., Avdoshina V. When human immunodeficiency virus meets chemokines and microglia: neuroprotection or neurodegeneration? // Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology.- 2013.- Vol. 8 (1).- P 118-31.

Canestri A., Lescure F.X., Jaureguiberry S., Moulignier A., Amiel C., Marcelin A.G., Peytavin G., Tubiana R., Pialoux G., Katlama C. Discordance between cerebralspinal fluid and plasma HIV replicationin patients with neurological symptomswho are receiving suppressive antiretroviraltherapy // Clin. Infect. Dis.- 2010.- Vol. 50.- P. 773-778.

Wendel K.A., McArthur J.C. Acute meningoencephalitis in chronic human immunodeficiencyvirus (HIV) infection: putativecentral nervous system escape of HIV replication // Clin. Infect. Dis.- 2003.- Vol. 37.- P 1107-1111.

Lee E., Gisslen M., Cinqu P., Brew B., Brew B., Peterson J., Sinclair E., Fuchs D., Hecht F., Price R., Spudich S. Early follow up of undetectable cerebrospinal fluid HIV-1 RNA during primary infection in the absence of ART // 19th Conference on Retroviruses and Opportunistic Infections (CROI). March 5-8, 2012; Seattle, Washington. Abstract 457.- URL: http://www.natap.org/2012/CROI/CROI.htm (дата обращения: 23.03.2013).http://www.natap.org/2012/CROI/CROI.htm

Mellberg T., Price R., Hagberg L. Decreased CSF Neurofilament Light Protein Concentrations after ART Initiation in Asymptomatic HIV-1+ Patients // 19th Conference on Retroviruses and Opportunistic Infections (CROI). March 5-8, 2012; Seattle, Washington. Abstract 469.- URL: http://www.natap.org/2012/CROI/CROI.htm (дата обращения: 23.03.2013).http://www.natap.org/2012/CROI/CROI.htm

Letendre S.L., Vaida F., Ellis R. Longitudinal Correlates of HIV RNA Levels in 2207 Cerebrospinal Fluid Specimens // 19th Conference on Retroviruses and Opportunistic Infections (CROI). March 5-8, 2012; Seattle, Washington. Abstract 473.- URL: http://www.natap.org/2012/CROI/CROI.htm (дата обращения: 23.03.2013).http://www.natap.org/2012/CROI/CROI.htm

Cardenas V.A., Meyerhoff D.J., Studholme C., Kornak J., Rothlind J., Lampiris H., Neuhaus J., Grant RM., Chao L.L., Truran D., Weiner M.W. Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy // Journal of Neurovirology.- 2009.- Vol. 15 (4), P. 324-333.

Дергилев А.П., Дворников П.Г., Грибачева И.А., Попова Т.Ф. Клинико-томографическая характеристика множественного очагового поражения белого вещества головного мозга // Журн. Клиническая и экспериментальная медицина.- 2003. - № 2. - С. 32-34.

Filippi C.G., Ulug A.M., Ryan E., Ferrando S.J., van Gorp W Diffusion tensor imaging of patients with HIV and normal-appearing white matter on MR images of the brain // AJNR Am J. Neuroradiol.- 2001.- Vol. 22.- P 277-283.

Cysique L., Moore D., Moffat K., Carr A., Brew B.J., Rae C. New evidence for cardiovascular-related Brain injury in middle-aged HIV+ individuals: A 1-H MRS Study // 19th Conference on Retroviruses and Opportunistic Infections (CROI). March 5-8, 2012; Seattle, Washington. Abstract 492.- URL: http://www.natap.org/2012/CROI/CROI.htm (дата обращения: 23.03.2013).http://www.natap.org/2012/CROI/CROI.htm

Davis H.F., Skolasky R.L., Selnes O.A., Burgess D.M., McArthur J.C. Assessing HIV-associated dementia: modified HIV dementia scale versus the Grooved Pegboard // AIDS Read.- 2002.- Vol. 12.- P. 29-38.

Morgan E.E., Woods S.P., Scott J.C., Childers M., Beck J.M., Ellis R.J., Grant I., Heaton R.K. Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale // J. Clin.Exp.Neuropsychol.- 2008.- Vol. 30.- P. 83-90.

Smith C.A., Van Gorp W.G., Ryan E.R., Ferrando S.J., Rabkin J. Screening subtle HIV-related cognitive dysfunction: the clinical utility of the HIV dementia scale // JAIDS.- 2003.- Vol.33.- P116-118.

Waldrop-Valverde D., Nehra R., Sharma S., Malik A., Jones D., Kumar A.M., Ownby R.L., Wanchu A., Weiss S., Prabhakar S., Kumar M. Education effects on the International HIV Dementia Scale // J. Neurovirol.- 2010.- Vol. 16.- P 264-267.

Heaton R.K., Clifford D.B., Franklin D.R., Woods S.P., Ake C., Vaida F., Ellis R.J., Letendre S.L., Marcotte T.D., Atkinson J.H., Rivera-Mindt M., Vigil O.R., Taylor M.J., Collier A.C., Marra C.M., Gelman B.B., McArthur J.C., Morgello S., Simpson D.M., McCutchan J.A., Abramson I., Gamst A., Fennema-Notestine C., Jernigan T.L., Wong J., Grant I. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study // Neurology.- 2010.- Vol. 75.- P. 2087-2096.

Heaton R.K., Marcotte T.D., Mindt M.R., Sadek J., Moore D.J., Bentley H., McCutchan J.A., Reicks C., Grant I. The impact of HIV-associated neuropsychological impairment on every day functioning // J. Int. Neuropsychol. Soc.- 2004.- Vol. 10.- P 317-331.

National Heart, Lung, and Blood Institute. Download our ATP III cholesterol management implementation tool for Palm OS. http://hp2010.nhlbihin.net/atpiii/atp3palm.htm.http://hp2010.nhlbihin.net/atpiii/atp3palm.htm

Беляков Н.А. Головной мозг как мишень для ВИЧ.- СПб.: Балтийский медицинский образовательный центр, 2011. - 48 с.

Carey C.L., Woods S.P., Gonzalez R., Conover E., Marcotte T.D., Grant I., Heaton R.K. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection // J. Clin. Exp. Neuropsychol.- 2004.- Vol. 26.- P. 307-319.

Everall I., Vaida F., Khanlou N., Lazzaretto D., Achim C., Letendre S., Moore D., Ellis R., Cherner M., Gelman B., Morgello S., Singer E., Grant I., Masliah E. Clinico-neuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy // J. Neurovirol.- 2009.- Vol. 15.- P. 360-370.

Трофимова Т.Н., Беляков Н.А. Многоликая нейрорадиология ВИЧ-инфекции // Лучевая диагностика и терапия.- 2010.- Т. 1, № 3.- С. 3-11.

Трофимова Т.Н., Беляков Н.А., Трофимова А.В., Щербук Ю.А. Общие особенности лучевой диагностики ВИЧ-ассоциированных поражений головного мозга // ВИЧ-инфекция и иммуносупрессии.- 2010.- Т. 2, № 1.- С. 51-60.

Гурская О.Е., Трофимова А.В., Рассохин В.В. Гайсина А.В., Катаева Г.В., Коротков А.Д., Медведев С.В., Спирин А.Л., Трофимова Т.Н. Особенности изменений функционального состояния головного мозга при ВИЧ-ассоциированной энцефалопатии // ВИЧ-инфекция и иммуносупрессии.- 2012.- Т. 4, № 1.- С. 82-87.

Беляков Н.А., Рассохин В.В., Сизова Т.Д., Гайсина А.В., Кольцова О.В., Пархоменко C.M., Громова Е.А. Особенности проявлений нейрокогнитивных расстройств у больных при ВИЧ-инфекции // ВИЧ-инфекция и иммуносупрессии. - 2013. - Т. 5, № 1. - С. 76-85.

Nath A., Clements J.E. Eradication of HIV from the brain: reasons for pause // AIDS.- 2011.- Vol. 25, № 5.- Р 577-580.

Winston A., Garvey L., Sabin C.A. Улучшение нейрокогнитивной функции зависит от проникновения препаратов в ЦНС только при использовании схем, включающих более трех антиретровирусных препаратов // AIDS, русское издание.- 2011.- Т. 4, № 2.- С. 228-229.

Valcour V., Paul R., Chiao S., Wendelken L.A., Miller B. Screening for cognitive impairmentin human immunodeficiency virus // Clin. Infect. Dis.- 2011.- Vol. 53.- P. 836-842.

Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program / The Mind Exchange Working Group // Clin. Infect. Dis.- 2013.- Vol. 56 (7).- Р. 1004-1017 doi:10.1093/cid/cis975..
DOI: 10.1093/cid/cis975